CVSOX
Price
$14.78
Change
-$0.22 (-1.47%)
Updated
Apr 4 closing price
Net Assets
15.47B
WMNUX
Price
$9.75
Change
-$0.02 (-0.20%)
Updated
Apr 4 closing price
Net Assets
148.76M
Ad is loading...

CVSOX vs WMNUX

Header iconCVSOX vs WMNUX Comparison
Open Charts CVSOX vs WMNUXBanner chart's image
Calamos Market Neutral Income R6
Price$14.78
Change-$0.22 (-1.47%)
VolumeN/A
Net Assets15.47B
Westwood Alternative Income Ultra
Price$9.75
Change-$0.02 (-0.20%)
VolumeN/A
Net Assets148.76M
CVSOX vs WMNUX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CVSOX vs. WMNUX commentary
Apr 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVSOX is a StrongBuy and WMNUX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
CVSOX has more cash in the bank: 15.5B vs. WMNUX (149M). WMNUX pays higher dividends than CVSOX: WMNUX (2.88) vs CVSOX (2.05). CVSOX was incepted earlier than WMNUX: CVSOX (5 years) vs WMNUX (10 years). CVSOX (0.89) is less costly to investors than WMNUX (0.47). WMNUX is a more actively managed with annual turnover of: 51.00 vs. CVSOX (35.00). CVSOX has a lower initial minimum investment than WMNUX: CVSOX (0) vs WMNUX (1000000). WMNUX annual gain was more profitable for investors over the last year : 7.14 vs. CVSOX (4.72).
CVSOXWMNUXCVSOX / WMNUX
Total Expense Ratio0.890.21424%
Annual Report Gross Expense Ratio0.890.47189%
Fund Existence5 years10 years-
Gain YTD-0.8211.795-46%
Front LoadN/AN/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets15.5B149M10,403%
Annual Yield % from dividends2.052.8871%
Returns for 1 year4.727.1466%
Returns for 3 years7.8915.6850%
Returns for 5 yearsN/A31.56-
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IRMCX10.39N/A
N/A
Voya Russell Mid Cap Index Port S
FGSAX51.29N/A
N/A
Federated Hermes MDT Mid Cap Growth A
PAMCX83.85N/A
N/A
T. Rowe Price Mid-Cap Growth Adv
GLNAX21.40N/A
N/A
MFS Global New Discovery A
IJSIX14.30N/A
N/A
VY® JPMorgan Small Cap Core Equity I